The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.41
Bid: 2.36
Ask: 2.50
Change: 0.00 (0.00%)
Spread: 0.14 (5.932%)
Open: 2.41
High: 0.00
Low: 0.00
Prev. Close: 2.41
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Poland

8 Jun 2018 18:25

RNS Number : 8551Q
Globalworth Real Estate Inv Ltd
08 June 2018
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this information is considered to be in the public domain.

 

8 June 2018

Globalworth Real Estate Investments Limited

("Globalworth" or the "Company")

Update on Poland

Further to its announcement of 28 February 2018, Globalworth is pleased to announce the execution of a commitment letter regarding the planned capital raise by Globalworth Poland Real Estate N.V. ("GPRE"), in which the Company has a 71.7% shareholding, which has also been launched today.

 

GPRE today announced that it is proceeding with the launch of an offering through which it targets to raise at least €450 million through the issue of new ordinary shares by way of private placement, which is expected to close on 11 June 2018 (the "GPRE Placing"). The net proceeds from the GPRE Placing will be used for the purchase of certain new properties, the repayment of certain loans (including those granted by the Company and its affiliates) and for general corporate purposes. A further announcement will be provided in due course.

 

In relation to this, the Company has agreed to subscribe for new ordinary shares by placing a subscription of a minimum of €300 million. Following the conclusion of the GPRE Placing, GPRE will repay equivalent amounts outstanding (including the principal, interest and any other amounts due) under the loans entered into between GPRE and the Company and its affiliates. As a result, the net investment in GPRE remains the same. The subscription will be made by one of the wholly owned subsidiaries of the Company. A further announcement will be provided in due course confirming the final subscription amount.

 

The commitment described above is subject to the following conditions: (a) the receipt by the Company of an underwriting fee equal to 1.5% of its respective equity investment for the commitment; and (b) the new ordinary shares being allotted and validly issued to the Company at the offer price of €1.57, as fully paid ordinary shares in the capital of GPRE (subject only to the admission to listing on the Warsaw Stock Exchange, which shall occur on or before 31 July 2018).

 

Globalworth's commitment as set out above also effectively satisfies one of the conditions to the commitment by Growthpoint Properties Limited ("Growthpoint") to participate in the GPRE placing, as announced on 12 April 2018, namely that Growthpoint would subscribe for no less than €120 million and no more than €150 million subject to Growthpoint's and its associates' total direct or indirect shareholding being less than 30.0% of the fully diluted share capital of GPRE.

 

Under Rule 13 of the AIM Rules for Companies, an issue of ordinary shares to a related party which exceeds 5% in any of the class tests would be treated as a related party transaction and is subject to certain disclosure and confirmation requirements.

 

To the extent that the board of directors of GPRE determines to go ahead with the GPRE Placing, the participation by Growthpoint (of a maximum amount of €150 million) will constitute a related party transaction under Rule 13 of the AIM Rules for Companies. As such, the Directors (other than Mr Sasse, Mr Muchanya and Mr Fechter, who are each directors of Growthpoint) consider, having consulted with the Company's nominated adviser, Panmure Gordon (UK) Limited ("Panmure Gordon"), that the terms of Growthpoint's participation in the GPRE Placing are fair and reasonable insofar as the Company's shareholders are concerned.

 

This transaction also represents a substantial transaction pursuant to the AIM Rules.

 

 

For further information visit www.globalworth.com or contact:

Enquiries

Andrew Cox Tel: +44 20 3026 4027

Head of Investor Relations & Corporate Development

Jefferies (Joint Broker) Tel: +44 20 7029 8000

Stuart Klein

Panmure Gordon (Nominated Adviser and Joint Broker) Tel: +44 20 7886 2500

Andrew Potts

Milbourne (Public Relations) Tel: +44 7903 802545

Tim Draper

 

About Globalworth / Note to Editors:

Globalworth is a listed real estate company active in Central and Eastern Europe, quoted on the AIM-segment of the London Stock Exchange. It has become the leading office investor in the Romanian real estate market and now has established a significant platform in Poland, through a 72% shareholding in Globalworth Poland, a pure-play Polish real estate platform listed on the Warsaw Stock Exchange. Globalworth acquires, develops and directly manages high-quality office and logistics/light-industrial real estate assets in prime locations, through which it benefits from a strong rental income profile from high quality tenants from around the globe. Managed by approximately 110 professionals across Romania and Poland, the combined value of its portfolio is €1.9 billion, of which over 90% is in income-producing assets, predominately in the office sector, and leased to some 440 national and multinational corporates from 28 countries and 37 different sectors. In Romania, Globalworth is present in Bucharest, Timisoara and Pitesti, whilst assets in Poland span Warsaw, Wroclaw, Lodz, Krakow, Gdansk and Katowice. For more information, please refer to http://www.globalworth.com/.

 

IMPORTANT NOTICE: This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom. This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. Save as required by law or regulation, the Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements in this announcement that may occur due to any change in its expectations or to reflect events or circumstances after the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBRGDLBDGBGII
Date   Source Headline
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price
28th Mar 20247:00 amRNSScrip Dividend Share Reference Price
26th Mar 20249:41 amRNSBuy back of Shares into Treasury and TVR
22nd Mar 20244:06 pmRNSPublication of Annual Report and Date of AGM
12th Mar 20244:04 pmRNSInterim Dividend & Scrip Alternative
11th Mar 20243:48 pmRNSTransfer of shares out of treasury
11th Mar 20243:35 pmRNSPreliminary results FY23
11th Mar 20243:03 pmRNSSale of part of logistics portfolio
24th Nov 202312:34 pmRNSS&P - 'BB+' Rating affirmed
27th Sep 20237:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
19th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSScrip Dividend Share Reference Price
30th Aug 20237:00 amRNSInterim Dividend & Scrip Alternative
29th Aug 20233:43 pmRNSNotice of Interim Results & Prelim Interim Results
4th Jul 20237:00 amRNSInvestment grade rating maintained - Correction
3rd Jul 20236:19 pmRNSFitch investment grade credit rating maintained
27th Jun 20232:25 pmRNSResults of Tender Offers
20th Jun 20239:22 amRNSTender Offers Launch for 2025 Notes & 2026 Notes
19th Jun 202310:55 amRNSResult of AGM
8th Jun 20239:27 amRNSMoody's Ratings Action and Withdrawal
17th May 20237:00 amRNSAGM Notice & Availability of Annual Report
14th Apr 20233:52 pmRNSDirectorate Change
4th Apr 202312:33 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20231:29 pmRNSBuy back of Shares into Treasury & TVR
24th Mar 20237:00 amRNSPosting of Annual Report and Date of AGM
23rd Mar 20237:00 amRNSScrip Dividend Share Reference Price
22nd Mar 20234:53 pmRNSS&P Rating Action
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:10 pmRNSInterim Dividend & Scrip Alternative
8th Mar 202312:12 pmRNSTransfer of Shares out of Treasury
8th Mar 202311:59 amRNSResult of EGM
3rd Mar 20237:00 amRNSCondensed Unaudited Results for FY 31 Dec 2022
24th Feb 20234:44 pmRNSNotice of EGM
23rd Dec 202210:30 amRNSNew Financing Facilities with the Erste Group
19th Dec 20227:00 amRNSCarbon Emissions Reduction Commitment
21st Oct 20223:00 pmRNSCEO succession
20th Sep 20227:00 amRNSHalf-year Report
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:01 amRNSInterim Dividend Payment
31st Aug 20227:00 amRNSNotice of Interim Results & Prelim Interim Info
8th Jul 20227:00 amRNSStatement re stated post-offer intentions
21st Jun 202212:15 pmRNSRepayment of Bond
20th Jun 202210:36 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.